Vistagen Therapeutics, Inc. · Brief

Next report

11 days

Nov 12 · after closeest.Q2 FY27

Expected move

No implied move.

—≥ implied

Q1 FY27±80.3%▲+0.49%×0.01

quarterimplied−85%0+85%realized×

Q1 FY27±80.3%▲+0.49%×0.01

Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Nov 12 report · est.

Bull2

+25.69%shares held by the ten largest reporting managers rose in the latest quarter13F · Jun 30 '26

4supplier and customer ties disclosed in SEC filingsSEC filings

Bear2

7 of 23of the largest reporting managers cut their stake in the latest quarter13F · Jun 30 '26

14managers whose positions together make up four fifths of the reported value concentrate ownership13F · Jun 30 '26

AI captions · Sep 28 '26once per report · top 2 per case

VTGN report session

No linked exposure.

No changes.

privateThesis 0 · Decisions 0 · Observations 0

No thesis.